207 related articles for article (PubMed ID: 24658070)
1. The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease.
Ma R; Cui Z; Hu SY; Jia XY; Yang R; Zheng X; Ao J; Liu G; Liao YH; Zhao MH
PLoS One; 2014; 9(3):e91250. PubMed ID: 24658070
[TBL] [Abstract][Full Text] [Related]
2. Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease.
Ma R; Cui Z; Liao YH; Zhao MH
J Clin Immunol; 2013 Jan; 33(1):172-8. PubMed ID: 22941511
[TBL] [Abstract][Full Text] [Related]
3. Complement in ANCA-associated glomerulonephritis.
Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
[TBL] [Abstract][Full Text] [Related]
4. Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease.
O'Flynn J; Kotimaa J; Faber-Krol R; Koekkoek K; Klar-Mohamad N; Koudijs A; Schwaeble WJ; Stover C; Daha MR; van Kooten C
Kidney Int; 2018 Dec; 94(6):1141-1150. PubMed ID: 30322716
[TBL] [Abstract][Full Text] [Related]
5. Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis.
Xing GQ; Chen M; Liu G; Zheng X; E J; Zhao MH
J Clin Immunol; 2010 Jan; 30(1):144-56. PubMed ID: 19898926
[TBL] [Abstract][Full Text] [Related]
6. Clinical-Pathological Features and Outcome of Atypical Anti-glomerular Basement Membrane Disease in a Large Single Cohort.
Shen CR; Jia XY; Cui Z; Yu XJ; Zhao MH
Front Immunol; 2020; 11():2035. PubMed ID: 33013861
[No Abstract] [Full Text] [Related]
7. [A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases].
Zhao M; Ding J; Liu Y; Zou W; Wang H
Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):316-20. PubMed ID: 11798594
[TBL] [Abstract][Full Text] [Related]
8. Unleashing the power of complement activation: unraveling renal damage in human anti-glomerular basement membrane disease.
Tang A; Zhao X; Tao T; Xie D; Xu B; Huang Y; Li M
Front Immunol; 2023; 14():1229806. PubMed ID: 37781380
[TBL] [Abstract][Full Text] [Related]
9. Glomerular C1q deposition and serum anti-C1q antibodies in anti-glomerular basement membrane disease.
Hu SY; Jia XY; Yang XW; Yu F; Cui Z; Zhao MH
BMC Immunol; 2013 Sep; 14():42. PubMed ID: 24053688
[TBL] [Abstract][Full Text] [Related]
10. Complement Activation Is Associated With Crescents in IgA Nephropathy.
Wang Z; Xie X; Li J; Zhang X; He J; Wang M; Lv J; Zhang H
Front Immunol; 2021; 12():676919. PubMed ID: 34594322
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
[TBL] [Abstract][Full Text] [Related]
12. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy.
Endo M; Ohi H; Ohsawa I; Fujita T; Matsushita M; Fujita T
Nephrol Dial Transplant; 1998 Aug; 13(8):1984-90. PubMed ID: 9719152
[TBL] [Abstract][Full Text] [Related]
13. Complement Activation in Kidneys of Patients With COVID-19.
Pfister F; Vonbrunn E; Ries T; Jäck HM; Überla K; Lochnit G; Sheriff A; Herrmann M; Büttner-Herold M; Amann K; Daniel C
Front Immunol; 2020; 11():594849. PubMed ID: 33584662
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor.
Okada M; Yoshioka K; Takemura T; Akano N; Aya N; Murakami K; Maki S
Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):367-73. PubMed ID: 8322453
[TBL] [Abstract][Full Text] [Related]
15. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.
Velosa J; Miller K; Michael AF
Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494
[TBL] [Abstract][Full Text] [Related]
16. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis.
Xing GQ; Chen M; Liu G; Heeringa P; Zhang JJ; Zheng X; E J; Kallenberg CG; Zhao MH
J Clin Immunol; 2009 May; 29(3):282-91. PubMed ID: 19067130
[TBL] [Abstract][Full Text] [Related]
17. Complement activation in early protocol kidney graft biopsies after living-donor transplantation.
Sund S; Hovig T; Reisaeter AV; Scott H; Bentdal Ø; Mollnes TE
Transplantation; 2003 Apr; 75(8):1204-13. PubMed ID: 12717204
[TBL] [Abstract][Full Text] [Related]
18. The distribution of IgG subclass deposition on renal tissues from patients with anti-glomerular basement membrane disease.
Qu Z; Cui Z; Liu G; Zhao MH
BMC Immunol; 2013 Apr; 14():19. PubMed ID: 23586976
[TBL] [Abstract][Full Text] [Related]
19. Sequential studies of glomerular crescent formation in rats with antiglomerular basement membrane-induced glomerulonephritis and the role of coagulation factors.
Silva FG; Hoyer JR; Pirani CL
Lab Invest; 1984 Oct; 51(4):404-15. PubMed ID: 6434880
[TBL] [Abstract][Full Text] [Related]
20. Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report.
Kojima T; Hirose G; Komatsu S; Oshima T; Sugisaki K; Tomiyasu T; Yoshikawa N; Yamada M; Oda T
BMC Nephrol; 2019 Jan; 20(1):25. PubMed ID: 30683055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
